About Us

Management Team

Michael R. Bristow, M.D., Ph.D,
President and Chief Executive Officer

 Dr. Bristow joined ARCA as one of ARCA’s founders in September 2004, and served as Chairman and Chief Science and Medical Officer of ARCA until he was appointed to his current position of President and Chief Executive Officer in July 2009. Dr. Bristow is a Professor of Medicine and the former Head of Cardiology at the University of Colorado Health Sciences Center, where he has been since October 1991. Dr. Bristow was one of the founders of Myogen, Inc. and served as Myogen’s Chief Science and Medical Officer from October 1996 to February 2006 and as a Scientific Advisor to Myogen from February 2006 until the acquisition of Myogen by Gilead Sciences, Inc. in November 2006.

Patrick Wheeler
Chief Financial Officer

Mr. Wheeler has held the position of Senior Vice President, Finance of the Company since February 2008. He joined ARCA in July 2006 as Vice President, Finance. Prior to joining ARCA, Mr. Wheeler served as Director of Finance for Dharmacon, Inc., A Fisher Scientific, Inc. life science company from June 2003 to July 2006. Mr. Wheeler has B.A. in economics from the University of Colorado and an M.B.A. from Regis University.

Christopher D. Ozeroff
Senior Vice President & General Counsel

Mr. Ozeroff was a co-founder of ARCA in September 2004 and has been its Executive Vice President of Business Development and General Counsel since that date. From August 1999, Mr. Ozeroff was previously a partner with the law firm of Hogan & Hartson L.L.P., where he practiced in such areas as finance, acquisitions, public offerings and licensing. Mr. Ozeroff completed his undergraduate degree at Stanford University, and his law degree at the University of Chicago Law School.


ARCA's Mission

... to develop and commercialize genetically-tailored therapies for heart failure and other cardiovascular diseases.

ARCA ©2014 ARCA biopharma | Home | Site Map | Legal Disclaimer